Table 9: The percentage of increase between new strategy and existing TSS for SRECFC4 fingerprints.

Activity Class Fusion Order and Range (%)
Renin ECFP4: R5 > R1 > R3 > R2 > R4 > FR (-6.11 - 5.07)
ECFC4: R5 > R4 > R3 > R1 > FR > R2 (-7.95 - 0.74)
SRECFC4: R2 > R1 > FR > R4 > R5 > R3 (-3.53 - 0.08)
AT1 ECFP4: R2 > FR > R5 > R3 > R4 > R1 (-2.07 - 1.18)
ECFC4: R5 > R2 > R4 > R3 > R1 > FR (-11.03 - 0.47)
SRECFC4: R4 > R2 > R3 > FR > R1 > R5 (3.97 - 6.41)
HIVP ECFP4: R1 > R4 > R2 > FR > R3 > R5 (10.39 - 29.13)
ECFC4: R4 > R3 > R5 > R1 > R2 > FR (4.83 - 30.38)
SRECFC4: R5 > R2 > R1 > R4 > R3 > FR (8.35 - 28.66)
Thrombin ECFP4: R1 > R5 > R4 > R2 > R3 > FR (4.81 - 31.06)
ECFC4: R5 > R2 > R3 > R1 > R4 > FR (16.89 - 28.59)
SRECFC4: R5 > R3 > R1 > R4 > R2 > FR (-10.70 - 14.34))
SubP ECFP4: R3 > R1 > R4 > R5 > R2 > FR (-21.54 - 2.94)
ECFC4: R3 > R4 > R1≈ R2 > R5 > FR (-10.23 - 4.77)
SRECFC4: R3 > R1 > R4 > R5 > R2 > FR (-10.70 - 14.34)
5HT3 ECFP4: R3 > R1 > R5 > FR > R4 > R2 (-5.25 - 8.60)
ECFC4: R3 > R4 > R2 > R1 > R5 > FR (6.14 - 31.45)
SRECFC4: R3 > R1 > R5 > R4 > R2 > FR (-1.30 - 15.38)
5HT
Reuptake
ECFP4: R1 > R3 > R4 > R5 > R2 > FR (14.96 - 31.77)
ECFC4: R1 > R5 > R3 > R4 > R2 > FR (0.43 - 20.37)
SRECFC4: R1 > R2 > R3 > R4 > FR > R5 (10.24 - 32.13)
D2 ECFP4: FR > R4 > R2 > R5 > R1 > R3 (9.16 - 29.73)
ECFC4: R4 > R5 > R2 > R1 > R3 > FR (13.38 - 25.00)
SRECFC4: R2 > FR > R1 > R5 > R1 > R3 (3.42 - 22.21)
5HT1A ECFP4: R4 > R3 > FR > R2 > R5 > R1 (3.93 to 12.25)
ECFC4: R5 > R4 > R1 > FR > R2 > R3 (13.63 to 26.44)
SRECFC4: R4 > R1 > R5 > R2 > FR > R1 (13.09 to 26.59)
PKC ECFP4: R3 > R5 > R4 > R2 > R1 > FR (6.67 - 45.86)
ECFC4: R1 > R5 > R2 > FR > R3 > R4 (8.66 -17.76)
SRECFC4: R2 > R4 > R3 > R1 > R5 > FR (11.88 - 22.77)
COX ECFP4: R1 > R5 > R4 > R3 > R2 > FR (15.56 - 30.93)
ECFC4: R2 > R5 > R3 > R1 > R4 > FR (-8.06 - 6.63)
SRECFC4: R5 > R2 > R3 > R1 > R4 > FR (9.16 - 50.32)